Aquinox Pharmaceutic (AQXP)
3.68 +0.21 (+6.05%) 08/09/19 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Fri, Aug 9th, 2019
Results
download Want to compare other data? Select Fields| Symbol | AQXP | TSHA | ASMB | ||
| Company | Aquinox Pharmaceutic | Taysha Gene Therapies Inc | Assembly Biosciences | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.50 | 1.1300 | 8.25 | ||
| High | 3.84 | 1.1600 | 8.32 | ||
| Low | 3.46 | 1.0500 | 8.00 | ||
| Last | 3.68 | 1.1150 | 8.15 | ||
| Change | +0.21 | -0.0150 | -0.11 | ||
| % Change | +6.05% | -1.33% | -1.33% | ||
| Volume | 513,900 | 590,717 | 59,417 | ||
| 20-Day Average Volume | 239,305 | 2,527,791 | 35,596 | ||
| Previous Close | 3.47 | 1.1300 | 8.26 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.78 | 1.5535 | 10.11 | ||
| 20-Day Raw Stochastic | 88.97% | 1.67% | 11.17% | ||
| 20-Day Relative Strength | 78.78% | 32.31% | 28.03% | ||
| Weighted Alpha | +32.80 | -60.90 | -55.24 | ||
| Today's Opinion | 72% Buy | 100% Sell | 100% Sell | ||
| Previous Opinion | 72% Buy | 100% Sell | 100% Sell | ||
| Last Month's Opinion | 64% Sell | 64% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +26.90% since 08/02/19 | -19.32% since 04/02/25 | -13.41% since 04/02/25 | ||
| Low | 2.41 on 08/06/19 | 1.0500 on 04/09/25 | 7.75 on 04/07/25 | ||
| High | 3.84 on 08/09/19 | 1.3200 on 04/03/25 | 9.98 on 04/03/25 | ||
| 1-Month | |||||
| %Chg | +52.07% since 07/09/19 | -39.14% since 03/07/25 | -26.26% since 03/07/25 | ||
| Low | 2.37 on 07/12/19 | 1.0500 on 04/09/25 | 7.75 on 04/07/25 | ||
| High | 3.84 on 08/09/19 | 1.9500 on 03/28/25 | 11.89 on 03/10/25 | ||
| 3-Month | |||||
| %Chg | +32.85% since 05/09/19 | -44.82% since 01/08/25 | -51.59% since 01/08/25 | ||
| Low | 2.19 on 06/06/19 | 1.0500 on 04/09/25 | 7.75 on 04/07/25 | ||
| High | 3.84 on 08/09/19 | 1.9500 on 03/28/25 | 16.90 on 01/10/25 | ||
| 6-Month | |||||
| %Chg | +50.20% since 02/08/19 | -46.75% since 10/09/24 | -48.75% since 10/09/24 | ||
| Low | 2.19 on 06/06/19 | 1.0500 on 04/09/25 | 7.75 on 04/07/25 | ||
| High | 3.84 on 08/09/19 | 3.3100 on 12/02/24 | 18.98 on 10/18/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 86,616 | 231,652 | 61,978 | ||
| Shares Outstanding, K | 23,537 | 205,002 | 7,503 | ||
| Annual Sales | 25,000,000 | 8,330,000 | 28,520,000 | ||
| Annual Net Income | -31,590,000 | -89,300,000 | -40,180,000 | ||
| Last Quarter Sales | 0 | 2,020,000 | 7,360,000 | ||
| Last Quarter Net Income | 0 | -18,780,000 | -10,340,000 | ||
| 60-Month Beta | -7.37 | 0.96 | 0.65 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.07 on 02/26/25 | -1.57 on 03/20/25 | ||
| Latest Earnings Date | 08/14/19 | 05/13/25 | 05/14/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||